Cargando…
A fatal primary gastric melanoma treated by a double immunotherapy with ipilimumab/nivolumab: description of a case report
BACKGROUND: Primary gastric melanoma (GM) is a very uncommon tumor with a poor prognosis. Until now, only a few cases have been reported in the literature. CASE DESCRIPTION: A 70-year-old, Caucasian, ex-smoker man, presented with asthenia, anorexia, and weight loss of 5 kg during the last 2 months....
Autores principales: | Longo, Raffaele, Colin, Sebastien, Streiff, Camille, Wendel, Chloé, Bonhomme, Axelle, Sava, Claudia, Campitiello, Marco, Plastino, Francesca, Egea, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660087/ https://www.ncbi.nlm.nih.gov/pubmed/36388646 http://dx.doi.org/10.21037/jgo-22-79 |
Ejemplares similares
-
Pituitary Metastasis from Renal Cell Carcinoma: Description of a Case Report
por: Wendel, Chloé, et al.
Publicado: (2017) -
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021) -
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
por: Wolchok, Jedd D., et al.
Publicado: (2022) -
Nivolumab plus ipilimumab in the treatment of advanced melanoma
por: Tsai, Katy K., et al.
Publicado: (2015) -
Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
por: Potluri, Ravi, et al.
Publicado: (2019)